Michael John Sumner - 04 Mar 2026 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Medical Officer
Signature: /s/ Michael John Sumner
Issuer symbol: INO
Transactions as of: 04 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 16:54:42 UTC
Previous filing: 27 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sumner Michael John	Chief Medical Officer	660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING	/s/ Michael John Sumner	05 Mar 2026	0001936799

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Common Stock Option	Award		+36,832		$0.000000^*	36,832	04 Mar 2026	Common Stock	36,832	$1.73	Direct	F1
transaction	INO	Restricted Stock Unit	Award		+29,608		$0.000000^*	29,608	04 Mar 2026	Common Stock	29,608		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The vesting schedule for the 36,832 options granted on March 4, 2026 was as follows: 12,278 shares will vest on February 26, 2027; 12,277 shares will vest on February 26, 2028; 12,277 shares will vest on February 26, 2029.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Content

The vesting schedule for the 36,832 options granted on March 4, 2026 was as follows: 12,278 shares will vest on February 26, 2027; 12,277 shares will vest on February 26, 2028; 12,277 shares will vest on February 26, 2029.

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.